Cipla News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Cipla Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 4
Author: Deven Choksey

Keep track of all breaking news and updates on Cipla from all sources in a single place.

Cipla Ltd.

11 Aug 2026

1458.80

-0.29%

Company Update

Cipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI …

BSE India

Please find attached disclosure on ESG Ratings.

pdf

Cipla Ltd.

07 Aug 2026

1458.80

-0.29%

Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS

Business Line

Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS

Cipla Ltd. is trading above all available SMAs

Cipla Ltd.

05 Aug 2026

1458.80

-0.29%

Karnataka attracts fresh investments from Cipla, Rocket India during Mumbai roadshow

Business Line

Karnataka's investment outreach gained momentum with major manufacturing expansion plans and fresh investor interest across infrastructure, renewable energy and industries.

Cipla Ltd. is trading above all available SMAs

Cipla Ltd.

04 Aug 2026

1458.80

-0.29%

Company Update

Cipla Ltd - 500087 - Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long …

BSE India

Please find enclosed intimation.

pdf

Cipla Ltd.

31 Jul 2026

1458.80

-0.29%

Company Update

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 31st July, 2026 has allotted 7,850 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Cipla ESOP Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.

pdf

Cipla Ltd.

30 Jul 2026

1458.80

-0.29%

Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS

Business Line

Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS

Cipla Ltd. has an average target of 1552.89 from 9 brokers.

Cipla Ltd.

27 Jul 2026

1458.80

-0.29%

Company Update

Cipla Ltd - 500087 - Cipla Receives U.S. FDA Approval For Generic Advair Diskus

BSE India

Please find enclosed disclosure

pdf

Cipla Ltd.

27 Jul 2026

1458.80

-0.29%

Earnings Call

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed Earnings Call Transcript - Q1FY27

pdf

Cipla Ltd.

27 Jul 2026

1458.80

-0.29%

Outlook

Accumulate: Cipla Ltd.

Target

Deven Choksey

We expect Cipla to deliver sustainable long-term growth, supported by the continued strength of its India formulations business, an improving chronic therapy mix, and a robust branded franchise.